Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Posted on 22/04/202522/04/2025 by sciencefather

Shah Nawaz Khan | Pharmaceutical Chemistry | Best Researcher Award

Dr. Shah Nawaz Khan, Shanghai Jiao Tong University, China

Dr. Shah Nawaz Khan, Ph.D. is a distinguished pharmaceutical chemist at Shanghai Jiao Tong University, specializing in organic synthesis, medicinal chemistry, and chemical biology. With a Ph.D. in Pharmaceutical Chemistry, his research spans photocatalytic decarboxylation, transition metal catalysis, and drug discovery. He has led projects on nucleoside antibiotics, shikonin derivatives, and natural product synthesis, contributing to cutting-edge solutions in biomedical innovation. Dr. Khan has an impressive publication record in high-impact journals and actively collaborates on international research initiatives.

Publication Profile

Orcid

Education

Dr. Shah Nawaz Khan 🎓 is a highly accomplished scholar in pharmaceutical sciences. He earned his Ph.D. in Pharmaceutical Chemistry from the School of Pharmacy, Shanghai Jiao Tong University 🇨🇳 (2016–2022). Prior to that, he completed his M.Phil. in Organic Synthesis at the University of Malakand 🇵🇰 (2012–2014), following his Doctor of Pharmacy degree from Gomal University (2004–2009). His academic journey began with an F.Sc. in Pre-Medical (2002–2004) and Matriculation in Science (2001–2002), both from Oxford Education Academy 🏫 in KPK, Pakistan. His strong educational foundation reflects a deep commitment to pharmaceutical research and academic excellence 🔬📚.

Experience

Dr. Shah Nawaz Khan 🔬 has extensive research experience in medicinal and pharmaceutical chemistry. Since Nov 2022, he has been a Postdoctoral Fellow at the School of Chemistry and Chemical Engineering, SJTU 🇨🇳, working on projects like the total synthesis of natural products (GR24), Ullmann coupling, and nucleoside synthesis. His Ph.D. (2016–2022) at SJTU focused on photocatalytic decarboxylative C-O, C-C, and C-N functionalization 🌟, using photoredox and transition metal catalysis. During his M.Phil. (2012–2014) at UOM 🇵🇰, he explored pharmacological activities and synthesized amide derivatives through one-pot reactions. His work bridges synthetic innovation and biological significance 🧪💊.

Awards

Dr. Shah Nawaz Khan 🏅 has been honored with several awards and certificates recognizing his academic, professional, and extracurricular contributions. He received certificates of appreciation for workshops and seminars on faculty development, allied health sciences, and nursing (2020–2022) 🎓. He earned a Personal Protective Equipment Training certificate during the COVID-19 pandemic 🦺 and was awarded the prestigious CSC Type A Scholarship 🇨🇳 in 2016. Earlier, he participated in the “GSK Gold Challenge” (2010), organized national-level declamation contests (2008), and alumni events (2007) 🗣️. Additionally, he holds over 10 sports certificates 🏆, reflecting a well-rounded and active educational journey.

Research Focus

Dr. Shah Nawaz Khan’s research centers on pharmaceutical chemistry and medicinal compound development, particularly emphasizing anticancer, antimicrobial, and antiviral agents. His work explores naphthoquinone derivatives, cyclopeptides, and photocatalytic processes, aiming to discover novel bioactive compounds for drug discovery and skin therapies. Additionally, he contributes to the understanding of molecular mechanisms of action and synthetic methodologies in organic chemistry. His research spans diverse fields including pharmacology, biotechnology, and chemical engineering, reflecting a multidisciplinary approach toward innovative therapeutic solutions. 🌱💊🧬 His cutting-edge investigations significantly impact disease treatment, drug design, and biomedical science.

Publication Top Notes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

A comprehensive study on the effects of annular protrusion for cavitation intensification in Venturi tubes

Exploiting the Anticancer, Antimicrobial and Antiviral Potential of Naphthoquinone Derivatives: Recent Advances and Future Prospects

Discovery of A Novel Cyclopeptide as Tyrosinase Inhibitor for Skin Lightening

Synthesis and germination activity study of novel strigolactam/strigolactone analogues

Decarboxylative oxidation-enabled consecutive C-C bond cleavage

Decarboxylative oxidation enabled consecutive C-C bond cleavage

Synthesis, characterization and antinociceptive activities of Novel 2-(2,4-dichlorophenyl)-4H-chromen-4-one

Pharmacological Activities and One Pot Two Step Synthesis of Novel (E)-N-(1-methyl-4-oxoimidazolidin-2-ylidene)benzamide

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Posted on 29/01/202529/01/2025 by sciencefather

Amedea B. Seabra | Pharmaceutical Chemistry | Excellence in Research

Assoc. Prof. Dr Amedea B. Seabra, Universidade Federal do ABC, Brazil

Assoc. Prof. Dr. Amedea B. Seabra is a renowned researcher in Chemistry at Universidade Federal do ABC (UFABC), Brazil. With a Ph.D. from UNICAMP, she specializes in biomaterials, nitric oxide release, and drug delivery systems. Her research includes developing novel materials for medical applications, such as nitric oxide-releasing hydrogels and vascular prostheses. Dr. Seabra has contributed significantly to projects related to wound healing and cardiovascular health. She has received numerous accolades, including recognition in global scientific databases and awards for her work on antimicrobial silver nanoparticles. 🌟🔬💉📚🌍

Publication Profile

Google Scholar

Academic Excellence

Assoc. Prof. Dr. Amedea B. Seabra holds a PhD in Chemistry from Universidade Estadual de Campinas (UNICAMP) and completed postdoctoral research at Concordia University and UNICAMP. Specializing in the controlled release of drugs, biomaterials, and nitric oxide chemistry, she has made significant contributions to both basic and applied sciences. Dr. Seabra’s work bridges the gap between research and practical applications, particularly in advancing drug delivery systems and exploring innovative biomaterials. Her research continues to have a profound impact on the development of therapeutic strategies for various medical challenges. 🧪💊🔬🌍

Professional Engagement

Assoc. Prof. Dr. Amedea B. Seabra is a distinguished academic with a wealth of experience in the field of biotechnology. Currently, she serves as the Vice Coordinator at the UFABC Graduate Program in Biotechnology and works as a collaborative researcher at the University of Edinburgh. Dr. Seabra has actively contributed to various international projects, including the prestigious Newton Advanced Fellowship. Her dedication to advancing research and fostering global collaborations highlights her commitment to scientific progress. 🌍🔬👩‍🔬💡

Awards and Recognition

Assoc. Prof. Dr. Amedea has made remarkable contributions to the scientific community, earning widespread recognition for her work. She was included in the prestigious Top 100,000 Scientists by C-Score and named among the most influential scientists globally in 2023 by Elsevier and Stanford University. Her exceptional achievements reflect her dedication and impact in her field. 🌍🔬📚🌟 Her ongoing research continues to inspire and drive advancements, solidifying her place as a leading figure in the scientific world. 👩‍🔬✨

Research Focus

Assoc. Prof. Dr. Amedea B. Seabra’s research focuses on nanotechnology, particularly the toxicology and antimicrobial properties of nanoparticles. Her studies investigate the synthesis, characterization, and biological effects of metal nanoparticles, such as silver and copper, including their cytotoxicity, genotoxicity, and environmental hazards. She has explored the potential of biogenically synthesized nanoparticles and their application in medicine, such as antimicrobial activity and toxicity in model organisms. Her work extends to the use of cellulose nanocrystals in medicine and addresses the risks posed by metal oxide nanoparticles. Overall, her research contributes to the safe application of nanomaterials. 🧬🧪⚛️